Amneal Pharmaceuticals reaffirms its previously issued financial guidance for the year 2022, including net revenue of $2.15 billion - $2.25 billion and adjusted EBITDA of $500 million - $520 million.
AI Assistant
AMNEAL PHARMACEUTICALS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.